ESRD

Advertisement
Sarah TolsonFrom the Field | March 8, 2025
Sarah Tolson highlights the concerns and challenges dialysis programs face under the 2025 ESRD PPS requirements.
Read More
Sarah TolsonFrom the Field | January 6, 2025
Sarah Tolson shares what billing departments of dialysis programs need to know about the CMS final rule for the ESRD PPS.
Charlotte RobinsonASN Kidney Week 2024 | December 3, 2024
Researchers studied the efficacy and safety of dapagliflozin in patients with chronic kidney disease stages 4 and 5.
Sarah TolsonFrom the Field | November 23, 2024
It is important to understand the challenges Medicare Advantage plans present for ESRD care.
Sagar Nigwekar, MD, MMScASN Kidney Week 2024 | November 19, 2024
Sagar Nigwekar discussed interim data from the SEAPORT 1 trial of INZ-701 for treatment of calciphylaxis.
Charlotte RobinsonASN Kidney Week 2024 | October 11, 2024
A late-breaking abstract at Kidney Week will report on a phase 3 trial of the ATEV in AV access for patients with ESRD.
Charlotte RobinsonNephrology Times | October 10, 2024
There is a gap in knowledge regarding the baseline risk of kidney disease in healthy patients with two APOL1 gene variants.
Charlotte RobinsonIgA Nephropathy | October 30, 2024
Patients with both IgAN and C2 lesions displayed a poor clinical prognosis requiring more effective treatment strategies.
Charlotte RobinsonNephrology Times | September 24, 2024
Researchers examined rates of incident dialysis and acute kidney injury among patients after heart failure hospitalization.
Charlotte RobinsonEnd-Stage Renal Disease | September 13, 2024
A bipartisan bill was introduced in the US Senate to ensure ESRD patients can access kidney care through private insurance.
Charlotte RobinsonEnd-Stage Renal Disease | September 9, 2024
Researchers examined data of patients starting kidney replacement therapy for ESRD due to primary glomerular disease.
Charlotte RobinsonADPKD | August 19, 2024
Data regarding mortality specific to patients with autosomal dominant polycystic kidney disease (ADPKD) are limited.
Sarah TolsonEnd-Stage Renal Disease | August 5, 2024
Including oral-only medications in a prospective payment model could pose challenges for dialysis providers and patients.
Charlotte RobinsonEnd-Stage Renal Disease | September 20, 2024
Researchers examined how cardiovascular health status differs between men and women with kidney failure.
Charlotte RobinsonEnd-Stage Renal Disease | July 24, 2024
Ardelyx is suing the HHS and CMS over their addition of oral phosphate-lowering drugs to a bundled payment system.
Charlotte RobinsonEnd-Stage Renal Disease | September 20, 2024
Why do patients drop out of peritoneal dialysis after switching from hemodialysis and how does it affect mortality?
Mohamed G. Atta, MD, MPHNephrology Times | July 25, 2024
Members of the Nephrology Times editorial board shared the nephrology research and news they’ve found most notable this ...
Charlotte RobinsonEnd-Stage Renal Disease | July 3, 2024
A large analysis examined variations in incident automated peritoneal dialysis prescriptions.
Charlotte RobinsonEnd-Stage Renal Disease | July 2, 2024
A rule proposed by CMS would update payment rates and policies under the End-Stage Renal Disease Prospective Payment Program.
Charlotte RobinsonEnd-Stage Renal Disease | June 19, 2024
Investigators identified distinct patterns in ESKD incidence among patients of different ages, sexes, and race.
Advertisement
Advertisement
Advertisement
Latest News

March 18, 2025